Zambia Ministry of Health, Lusaka, Zambia.
Department of Infectious Diseases, University Teaching Hospital, Lusaka, Zambia.
Clin Infect Dis. 2021 Sep 15;73(6):e1321-e1328. doi: 10.1093/cid/ciab273.
Healthcare workers (HCWs) in Zambia have become infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). However, SARS-CoV-2 prevalence among HCWs is not known in Zambia.
We conducted a cross-sectional SARS-CoV-2 prevalence survey among Zambian HCWs in 20 health facilities in 6 districts in July 2020. Participants were tested for SARS-CoV-2 infection using polymerase chain reaction (PCR) and for SARS-CoV-2 antibodies using enzyme-linked immunosorbent assay (ELISA). Prevalence estimates and 95% confidence intervals (CIs), adjusted for health facility clustering, were calculated for each test separately, and a combined measure for those who had PCR and ELISA was performed.
In total, 660 HCWs participated in the study, with 450 (68.2%) providing a nasopharyngeal swab for PCR and 575 (87.1%) providing a blood specimen for ELISA. Sixty-six percent of participants were females, and median age was 31.5 years (interquartile range, 26.2-39.8). The overall prevalence of the combined measure was 9.3% (95% CI, 3.8%-14.7%). PCR-positive prevalence of SARS-CoV-2 was 6.6% (95% CI, 2.0%-11.1%), and ELISA-positive prevalence was 2.2% (95% CI, .5%-3.9%).
SARS-CoV-2 prevalence among HCWs was similar to a population-based estimate (10.6%) during a period of community transmission in Zambia. Public health measures such as establishing COVID-19 treatment centers before the first cases, screening for COVID-19 symptoms among patients who access health facilities, infection prevention and control trainings, and targeted distribution of personal protective equipment based on exposure risk might have prevented increased SARS-CoV-2 transmission among Zambian HCWs.
赞比亚的医疗工作者(HCWs)已感染导致 2019 年冠状病毒病(COVID-19)的严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)。然而,赞比亚 HCWs 中 SARS-CoV-2 的流行情况尚不清楚。
我们于 2020 年 7 月在赞比亚 6 个地区的 20 个卫生机构中对 HCWs 进行了 SARS-CoV-2 患病率横断面调查。使用聚合酶链反应(PCR)检测参与者的 SARS-CoV-2 感染情况,使用酶联免疫吸附测定(ELISA)检测 SARS-CoV-2 抗体。针对每个检测单独计算了患病率估计值和 95%置信区间(CI),并对卫生机构聚类进行了调整,对同时进行 PCR 和 ELISA 的人进行了联合检测。
共有 660 名 HCWs 参加了研究,其中 450 名(68.2%)提供了鼻咽拭子用于 PCR,575 名(87.1%)提供了血液样本用于 ELISA。66%的参与者为女性,中位年龄为 31.5 岁(四分位间距,26.2-39.8)。联合检测的总体患病率为 9.3%(95%CI,3.8%-14.7%)。PCR 阳性 SARS-CoV-2 的患病率为 6.6%(95%CI,2.0%-11.1%),ELISA 阳性的患病率为 2.2%(95%CI,0.5%-3.9%)。
赞比亚 HCWs 的 SARS-CoV-2 患病率与社区传播期间的人群估计值(10.6%)相似。公共卫生措施,如在赞比亚首例病例出现之前建立 COVID-19 治疗中心、对前往医疗机构就诊的患者进行 COVID-19 症状筛查、感染预防和控制培训以及根据接触风险有针对性地分发个人防护设备,可能防止了 SARS-CoV-2 在赞比亚 HCWs 中的传播增加。